Literature DB >> 8094190

Cyclosporin absorption from microemulsion formulation in liver transplant recipient.

A K Trull, K K Tan, J Uttridge, T Bauer, G J Alexander, N V Jamieson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8094190     DOI： 10.1016/0140-6736(93)93025-v

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.

Authors:  Terry E Jones; Raymond G Morris
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 4.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 5.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

6.  Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis.

Authors:  K K Tan; A K Trull; J A Uttridge; J Wallwork
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.

Authors:  A K Trull; K K Tan; L Tan; G J Alexander; N V Jamieson
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

Review 8.  Biopharmaceutical insights of particulate emulsified systems - a prospective overview.

Authors:  Jyothshna Devi Katamreddy; Prasanna Raju Yalavarthi; Subba Rao D; Sowjanya Battu; Jaya Preethi Peesa
Journal:  Lipids Health Dis       Date:  2018-05-10       Impact factor: 3.876
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.